Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Infections and Infectious Diseases | Family Medicine
HIV Clinical Trials
A listing of HIV medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Phoenix : Southwest Center for HIV/AIDS
Are You Living with HIV and Have Type 2 Diabetes?
Phoenix : Southwest Center for HIV/AIDS
Help Find More Efficient Ways to Test for HIV
California
Los Angeles : Charles R. Drew University - Clinical Research Center
Testosterone Replacement and Physical Function in HIV-Associated Weight Loss.
View More »
Los Angeles : UCLA Care Center
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Los Angeles : LAC+USC MCA Clinic
Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma
Newport Beach : Orange Coast Medical Group
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Diego : UCSD Antiviral Research Center
Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
San Francisco : Quest Clinical Research
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Francisco : San Francisco VA Medical Center
High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Connecticut
Norwalk : Circle CARE Center, LLC
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
District of Columbia
Washington : Children'S National Medical Center
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Florida
Daytona Beach :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Fort Lauderdale : Gary Richmond, MD, PA, Inc.
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Fort Pierce : Midway Immunology & Research Center, LLC
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Ft. Lauderdale : TheraFirst Medical Center
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Miami :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
View More »
Orlando : Orlando Immunology Center
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Orlando : IDOCF/ValuHealthMD, LLC
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Orlando : Orlando Immunology Center
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Port Saint Lucie :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
West Palm Beach :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Georgia
Atlanta : AIDS Research Consortium of Atlanta
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Decatur : Infectious Disease Specialist of Atlanta
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Illinois
Chicago : Ruth M. Rothstein CORE Center
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
Kentucky
Lexington : University of Kentucky Chandler Medical Center
HIV Positive Infected Patients Needed For an Observational Study of The Safety of MARAVIROC
Maryland
Bethesda : NIH Department of Laboratory Medicine
A Phase 2a Study of GS-6624 in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Massachusetts
Boston : Massachusetts General Hospital
Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients
Boston : Fenway Health
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Rockland : Call EMD Serono Medical Information for information on recruiting sites
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Rockland : Call EMD Serono Medical Information for Recruiting Sites Updated
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
Rockland : Call EMD Serono Medical Information for information on recruiting sites Updated
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
Michigan
Berkley : Be Well Medical Center
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Missouri
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Young adults, 18 - 24 years of age, are needed for a research study.
View More »
St Louis : Central West Clinical Research, Inc.
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
St Louis : Central West Clinical Research, Inc.
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
New Mexico
Santa Fe : Southwest CARE Center
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
New York
Bronx : Biomedical Research Alliance of New York
HIV - Adults
Manhasset : Biomedical Research Alliance of New York
Clinical trial to test how well study drug is tolerated in HIV-1 infected individuals.
Manhasset : Biomedical Research Alliance of New York
HIV and Renal Impairment
Manhasset : Biomedical Research Alliance of New York
HIV-1 Virus Infection - Adults
View More »
Bronx :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
New York : Ricky K Hsu, MD, PC
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
New York : Mount Sinai School of Medicine
Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
New York : Chelsea Village Medical
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Syracuse : Suny Upstate Medical University
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
North Carolina
Chapel Hill :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Chapel Hill : UNC Infectious Disease Clinic
Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir
Texas
Austin : Central Texas Clinical Research
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Houston : Gordon Crofoot, MD, PA
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Houston : Thomas Street Health Center-HCHD
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Houston : The University of Texas Health Science Center at Houston
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
Virginia
Annandale : Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)
Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Washington
Argentina
Buenos Aires : Helios Salud
Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Buenos Aires : FUNCEI
Maraviroc Switch Collaborative Study
Buenos Aires : Hospital G de Agudos JM Ramos Mejia
Maraviroc Switch Collaborative Study
Buenos Aires : Hospital Italiano de Buenos Aires
Maraviroc Switch Collaborative Study
Buenos Aires : Fundacion IDEAA
Maraviroc Switch Collaborative Study
View More »
Buenos Aires, Bs As : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Bunos Aires : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
La Plata : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Rosario : CAICI
Maraviroc Switch Collaborative Study
Australia
Adelaide : O'Brien Street Practice
Maraviroc Switch Collaborative Study
Bisbane : Gladstone Road Medical Centre
Maraviroc Switch Collaborative Study
Brisbane : Brisbane Sexual Health and HIV Service (formerly AMU)
Maraviroc Switch Collaborative Study
Melbourne : Alfred Hospital
Maraviroc Switch Collaborative Study
Melbourne : Monash Medical Centre
Maraviroc Switch Collaborative Study
View More »
Melbourne : Royal Melbourne Hospital
Maraviroc Switch Collaborative Study
Nambour : Nambour General Hospital
Maraviroc Switch Collaborative Study
Sydney : Holdsworth House Medical Practice
Maraviroc Switch Collaborative Study
Sydney : Royal Prince Alfred Hospital
Maraviroc Switch Collaborative Study
Sydney : Westmead Hospital
Maraviroc Switch Collaborative Study
Sydney : St. Vincent's Hospital
Maraviroc Switch Collaborative Study
Sydney : St Vincent Hospital, Clinical Research Program
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Sydney : Holdsworth House Medical Practice
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Brazil
Porto Alegre : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Recife : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Sao Paolo : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Burkina Faso
Bobo Dioulasso : Day Hospital, CHU Sanou Souro
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Cameroon
Yaounde : Day Hospital, Central Hospital
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Canada
Calgary : Southern Alberta Clinic
Maraviroc Switch Collaborative Study
Montreal : Clinic Opus/Lori
Maraviroc Switch Collaborative Study
Montreal : Montreal Chest Institute
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Toronto : Canadian Immunodeficiency Research Collaborative (CIRC) lnc (Maple Leaf Clinic)
Maraviroc Switch Collaborative Study
Toronto : University Health Network/Toronto General Hospital
Maraviroc Switch Collaborative Study
View More »
Toronto : University Health Network - Toronto General Hospital Division
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Vancouver : Providence Health Care- St. Paul's Hospital
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Chile
Santiago : Fundación Arriarán
Maraviroc Switch Collaborative Study
Santiago : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
China
Beijing : Division of Treatment and Care, NCAIDS, China CDC
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Beijing : National Center for AIDS/STD Control and Prevention, China CDC
Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection
France
Germany
Aachen : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Berlin : Gemeinschaftspraxis Jessen Jessen Stein
Maraviroc Switch Collaborative Study
Berlin : Dienstleistung centre ID (Baumgarten, MIB medical center for infectious diseases)
Maraviroc Switch Collaborative Study
Berlin : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Bochum : University Hospital of Bochum, Department of Dermatology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
View More »
Bonn : University of Bonn, Med J. Immunologische Siudienzenirale
Maraviroc Switch Collaborative Study
Cologne : Klinikum der Universitat Zu Koln
Maraviroc Switch Collaborative Study
Dortmund : HIV Outpatient Department
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Duisburg : Health Center
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Dusseldorf : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Düsseldorf : Universitätsklinikum Düsseldorf, Klinik für Gastroenterologie, Hepatologie und Infektiologie-MX- Amb
Maraviroc Switch Collaborative Study
Essen : University Hospital, West German Heart Center Essen
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Essen : University Hospital, Department of Dermatology and Venerology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Frankfurt : Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER
Maraviroc Switch Collaborative Study
Frankfurt/Main : HIV Treatment & Research Unit, Dept. of Internal Medicine II, Hospital of the Johann Wolfgang Goethe University Frankfurt/Main
A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients
Freiburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Hamburg : ICH Study Center Hamburg
Maraviroc Switch Collaborative Study
Hamburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Hannover : Klinik für Immunologie und Rheumatologie, Medzinische Hochschule Hannover
Maraviroc Switch Collaborative Study
Hannover : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Munchen : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Regensburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Stuttgart : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Ireland
Italy
Varese : Ospedale di Circolo and Fondazione Macchi
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
Japan
Nagoya : Nagoya Medical Center
Maraviroc Switch Collaborative Study
Mexico
Df : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Guadalajara : Hospital Civil de Guadalajara
Maraviroc Switch Collaborative Study
Guadalajara : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Leon : Hospital General de Leon
Maraviroc Switch Collaborative Study
Merida : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
View More »
Mexico City : INCMNSZ
Maraviroc Switch Collaborative Study
Oaxaca : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Poland
Warszawa : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Portugal
Aveiro : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Barreiro : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Lisboa : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Porto : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Pragal : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
View More »
Santarem : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Sao Martinho do Bispo : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Vila Nova de Gaia : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Puerto Rico
San Juan : Clinical Research Puerto Rico
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Juan Pr :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Romania
Bucharest : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Russian Federation
Senegal
Dakar : Clinical Research and Training Center, Fann Hospital
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
South Africa
Benoni : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Bloemfontein : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Parrow Valley : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Port Elizabeth : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Pretoria : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
View More »
Soweto : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Spain
Badalona : Hospital Germans Trias i Pujol
Maraviroc Switch Collaborative Study
Badalona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Barcelona : Hospital Clínic de Barcelona
Maraviroc Switch Collaborative Study
Barcelona : Hospital de la Santa Creu i Sant Pau
Maraviroc Switch Collaborative Study
Barcelona : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
View More »
Barcelona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Granada : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Granollers : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Guadalajara : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Jerez de la Frontera : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Leganes : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Logrono : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Madrid : Hospital General Universitario Gregorio Marañón (HGUGM)
Maraviroc Switch Collaborative Study
Madrid : Hospital La Paz,
Maraviroc Switch Collaborative Study
Madrid : Hospital Principe de Asturias
Maraviroc Switch Collaborative Study
Madrid : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Madrid : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Malaga : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Marbella : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Mataro : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Mostoles : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Santiago de Compostela : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Sevilla : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Tarragona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Valencia : Hospital Universitari i Politecnic La Fe
Maraviroc Switch Collaborative Study
Valencia : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Thailand
Uganda
Fort Portal : JCRC Fort Portal
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Gulu : JCRC Gulu
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Kabale : JCRC Kabale
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Kakira : JCRC Kakira
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Kampala : JCRC Kampala
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
View More »
Kampala : San Raphael of St Francis Hospital, Nsambya
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Kampala : Infectious Diseases Institute (IDI)
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Mbale : JCRC Mbale
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Mbarara : JCRC Mbarara
EARNEST Rifabutin Pharmacokinetics (PK) Substudy
United Kingdom
Birmingham : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Brighton : Brighton & Sussex University NHS Trust
Maraviroc Switch Collaborative Study
Guildford : Surrey Clinical Research Centre University of Surrey
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
London : St. Mary's Hospital, Imperial College
Maraviroc Switch Collaborative Study
London : Chelsea and Westminster Hospital
Maraviroc Switch Collaborative Study
View More »
London : Imperial College Healthcare NHS Trust
The Rilpivirine Cerebrospinal-fluid (CSF) Study
